Q: I have a small position in PFE (about 1%), and I am interested in increasing my position to about 2%-2.5% by selling off a similarly-sized position in BAC. My portfolio has about a 10% weighting in financials, while I only have about 4% in health care, which is why I wanted to make the shift. My question is whether I am better off simply topping up my PFE position, or selling PFE as well as BAC, and using the proceeds to buy either JNJ, MRK or GSK. I prefer to stay with larger cap names, and in this particular case, I am looking at US names exclusively. If you have another larger cap US name that may be worth considering, I would be very open to suggestions.
As an aside, I also have a 3% position in GUD which I plan to keep for the longer term.
Thanks so much for your time, and I look forward to your response.
As an aside, I also have a 3% position in GUD which I plan to keep for the longer term.
Thanks so much for your time, and I look forward to your response.